The purpose of the clinical core is to provide pathologic data, clinical information and blood and tissue samples on ANCA glomerulonephritis (ANCA-GN) patients for three of the five proposed projects. The clinical core consists of five components that already exist and that have an ongoing establish and interconnected working relationship. The five components include 1) the UNC Nephropathology Laboratory, 2) the UNC Glomerulonephritis and Vasculitis 5) a statistician/epidemiologist. Working together, the components of this core have established the ability to public abstracts and manuscripts. The UNC Nephropathology Laboratory evaluates approximately 1,500 renal biopsy specimens per year with approximately 15% from the UNCS Glomerulonephritis have joined together with Drs. Ronald J. Falk and J. Charles Jeanette of UNC to form a research collaboration called the GDCN. The mainstay of the GDCN has been the maintenance an ANCA- GN patient registry. Clinical information is collected on over 250 patients diagnosed since 1986. Registry patients are followed from the onset of symptoms until death. Registry data has provided information for manuscripts on clinical presentation, disease associations, treatment response, environmental associations, and on prognostic markers for dialysis, death and disease relapses. The core will identify patients for participation in the Environmental Factors in ANCA-GN study (Project #5) and will maintain long-term follow-up of these patients to evaluate the role of environmental factors in disease progression. The registry provides a pool of patients for collecting blood samples. Samples can be collected at the UNC Glomerulonephritis and Vasculitis Clinic and from the GDCN practices for collecting blood samples. Samples can be collected at the UNC Glomerulonephritis and Vasculitis Clinic and from the GDCN practices. Blood samples will be needed on numerous patients during various stages of Vitro Analysis of ANCA- Induced Glomerular Inflammation (Project 3). In summary, the core will play a critical role in identifying patients and obtaining blood samples and clinical information at these various clinical stages of the disease. The core will also provide support for statistical analysis. The core has demonstrated the ability to work collaboratively and can meet the clinical research needs of the program project.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Program Projects (P01)
Project #
3P01DK058335-02S1
Application #
6590333
Study Section
Special Emphasis Panel (ZDK1)
Project Start
2001-09-01
Project End
2002-08-31
Budget Start
Budget End
Support Year
2
Fiscal Year
2002
Total Cost
$167,151
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
078861598
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
McCall, A Scott; Bhave, Gautam; Pedchenko, Vadim et al. (2018) Inhibitory Anti-Peroxidasin Antibodies in Pulmonary-Renal Syndromes. J Am Soc Nephrol 29:2619-2625
Alba, Marco A; Jennette, J Charles; Falk, Ronald J (2018) Pathogenesis of ANCA-Associated Pulmonary Vasculitis. Semin Respir Crit Care Med 39:413-424
Weiner, Maria; Bjørneklett, Rune; Hrušková, Zdenka et al. (2018) Proteinase-3 and myeloperoxidase serotype in relation to demographic factors and geographic distribution in anti-neutrophil cytoplasmic antibody-associated glomerulonephritis. Nephrol Dial Transplant :
van Daalen, Emma E; Jennette, J Charles; McAdoo, Stephen P et al. (2018) Predicting Outcome in Patients with Anti-GBM Glomerulonephritis. Clin J Am Soc Nephrol 13:63-72
Thorpe, Carolyn T; Thorpe, Joshua M; Jiang, Tao et al. (2018) Healthcare utilization and expenditures for United States Medicare beneficiaries with systemic vasculitis. Semin Arthritis Rheum 47:507-519
Alba, Marco A; Flores-Suárez, Luis Felipe; Henderson, Ashley G et al. (2017) Interstital lung disease in ANCA vasculitis. Autoimmun Rev 16:722-729
Cortazar, Frank B; Pendergraft 3rd, William F; Wenger, Julia et al. (2017) Effect of Continuous B Cell Depletion With Rituximab on Pathogenic Autoantibodies and Total IgG Levels in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis Rheumatol 69:1045-1053
Payan Schober, Fernanda; Jobson, Meghan A; Poulton, Caroline J et al. (2017) Clinical Features and Outcomes of a Racially Diverse Population with Fibrillary Glomerulonephritis. Am J Nephrol 45:248-256
Jones, Britta E; Yang, Jiajin; Muthigi, Akhil et al. (2017) Gene-Specific DNA Methylation Changes Predict Remission in Patients with ANCA-Associated Vasculitis. J Am Soc Nephrol 28:1175-1187
Merkel, Peter A; Xie, Gang; Monach, Paul A et al. (2017) Identification of Functional and Expression Polymorphisms Associated With Risk for Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis. Arthritis Rheumatol 69:1054-1066

Showing the most recent 10 out of 86 publications